| First Author | Ji W | Year | 2015 |
| Journal | Cancer Res | Volume | 75 |
| Issue | 17 | Pages | 3492-504 |
| PubMed ID | 26139244 | Mgi Jnum | J:225590 |
| Mgi Id | MGI:5693683 | Doi | 10.1158/0008-5472.CAN-15-0088 |
| Citation | Ji W, et al. (2015) AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis. Cancer Res 75(17):3492-504 |
| abstractText | Studies from tumor cells suggest that tumor-suppressor AIP1 inhibits epithelial-mesenchymal transition (EMT). However, the role of AIP1 in the tumor microenvironment has not been examined. We show that a global or vascular endothelial cell (EC)-specific deletion of the AIP1 gene in mice augments tumor growth and metastasis in melanoma and breast cancer models. AIP1-deficient vascular environment not only enhances tumor neovascularization and increases premetastatic niche formation, but also secretes tumor EMT-promoting factors. These effects from AIP1 loss are associated with increased VEGFR2 signaling in the vascular EC and could be abrogated by systemic administration of VEGFR2 kinase inhibitors. Mechanistically, AIP1 blocks VEGFR2-dependent signaling by directly binding to the phosphotyrosine residues within the activation loop of VEGFR2. Our data reveal that AIP1, by inhibiting VEGFR2-dependent signaling in tumor niche, suppresses tumor EMT switch, tumor angiogenesis, and tumor premetastatic niche formation to limit tumor growth and metastasis. Cancer Res; 75(17); 3492-504. (c)2015 AACR. |
